IP Library › Granted Patent US 8,524,900
Granted Patent B2
US 8,524,900 · App. 13/309,488 · Granted Sep 3, 2013

Fused heterocyclic derivatives and methods of use

Inventors: Brian K. Albrecht (Cambridge, MA); David Bauer (Sudbury, MA); Christiane M. Bode (Somerville, MA); Shon Booker (Thousand Oaks, CA); Alessandro Boezio (Somerville, MA); Deborah Choquette (Medford, MA); Derin D'Amico (Newbury Park, CA); Jean-Christophe Harmange (Andover, MA); Satoko Hirai (Cambridge, MA); Richard T. Lewis (Farmingham, MA); Longbin Liu (Thousand Oaks, CA); Julia Lohman (Cambridge, MA); Mark H. Norman (Thousand Oaks, CA); Michele Potashman (Cambridge, MA); Aaron C. Siegmund (Ventura, CA); Stephanie K. Springer (Cambridge, MA); Markian Stec (Moorpark, CA); Ning Xi (Thousand Oaks, CA); Kevin Yang (San Gabriel, CA)
Assignee: Amgen Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,524,900
App. No.
13/309,488
Granted
Sep 3, 2013
Kind
B2
Abstract

Selected compounds are effective for prophylaxis and treatment of diseases, such as HGF mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

Claims (9)

1. A compound selected from

or a pharmaceutically acceptable salt thereof.

2. A compound or a pharmaceutically acceptable salt thereof, selected from

3. A compound or a pharmaceutically acceptable salt thereof, selected from

4. A compound or a pharmaceutically acceptable salt thereof, selected from

5. A pharmaceutical composition comprising a compound of any of claim 1 , 2 , 3 or 4 together with a pharmaceutically acceptable vehicle or carrier.

6. A compound or a pharmaceutically acceptable salt thereof, selected from

7. A pharmaceutical composition comprising a compound of claim 6 together with a pharmaceutically acceptable vehicle or carrier.

8. A method of treating gastric cancer or glioblastoma in a subject, said method comprising administering an effective amount of a compound as in any of the preceding claims.

Continuity (4)
Division 12009123 · Jan 15, 2008
Continuation In Part 11879034 · Jul 13, 2007
Provisional Application 60830882 · Jul 14, 2006
Related Publication 20120148531A1 · Jun 14, 2012